BACE1 RNAi restores the composition of phosphatidylethanolamine-derivates related to memory improvement in aged 3xTg-AD mice
β-amyloid (Aβ) is produced by the β-secretase 1 (BACE1)-mediated enzymatic cleavage of the amyloid precursor protein through the amyloidogenic pathway, making BACE1 a therapeutic target against Alzheimer’s Disease (AD). Alterations in lipid metabolism are a risk factor for AD by an unknown mechanism...
Main Authors: | Javier Gustavo Villamil, Alvaro Barrera-Ocampo, Diego Piedrahita, Claudia Maria Velasquez-Rodriguez, Julian David Arias-Londoño, Gloria Patricia Cardona Gomez |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-11-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fncel.2016.00260/full |
Similar Items
-
BACE1 and SCD1 are associated with neurodegeneration
by: Ferley A. Bedoya-Guzmán, et al.
Published: (2023-09-01) -
A Tale of Two Drug Targets: The Evolutionary History of BACE1 and BACE2
by: Christopher eSouthan, et al.
Published: (2013-12-01) -
The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer
by: Arezou Sayad, et al.
Published: (2022-03-01) -
Development and Structural Modification of BACE1 Inhibitors
by: Ting Gu, et al.
Published: (2016-12-01) -
Role of BACE1 in Alzheimer’s synaptic function
by: Brati Das, et al.
Published: (2017-08-01)